Drug
Lasmiditan clinical trials
Also written LY573144.
- studies test it
- 32
- open now
- 0
- in phase 3
- 7
- first study started
- 2006
How studies write it
Studies that test it under each name
Studies by the year they started
32 studies that test it; most in 2017 (12)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 12 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 22
- Phase 2
- 3
- Phase 3
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 32 · Other 0
Eli Lilly and Company (30) · IlDong Pharmaceutical Co Ltd (2)
Often tested with
Tested in the same studies.
Sumatriptan (2) · Rosuvastatin (1) · Propranolol (1) · Topiramate (1)
Studies
Open first, then newest update. How each study uses lasmiditan is read from its arms, and is right about nine times in ten.
Testing it · 32
- A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineTerminatedPhase 3Eli Lilly and CompanyNCT04396236Written as Lasmiditan
- A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineTerminatedPhase 3Eli Lilly and CompanyNCT04396574Written as Lasmiditan
- A Study of Lasmiditan in Healthy VolunteersCompletedPhase 1Eli Lilly and CompanyNCT04749914Written as Lasmiditan
- A Study to Compare Two Different Formulations of Lasmiditan in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT04881747Written as Lasmiditan
- A Study of Lasmiditan (LY573144) Over Four Migraine AttacksCompletedPhase 3Eli Lilly and CompanyNCT03670810Written as Lasmiditan
- A Study of Lasmiditan in Healthy Chinese ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT04081324Written as Lasmiditan
- A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With MigraineCompletedPhase 2Eli Lilly and CompanyNCT03962738Written as Lasmiditan
- Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in KoreanCompletedPhase 3IlDong Pharmaceutical Co LtdNCT04218162Written as Lasmiditan 50mg
- A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With MigraineCompletedPhase 1Eli Lilly and CompanyNCT03988088Written as Lasmiditan
- An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of MigraineCompletedPhase 3Eli Lilly and CompanyNCT02565186Written as Lasmiditan
- A Study of Lasmiditan on the Heart in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT03465436Written as Lasmiditan
- A Study of Lasmiditan on Simulated Driving Performance in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT03459612Written as Lasmiditan
- Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose AdministrationCompletedPhase 1Eli Lilly and CompanyNCT03040362Written as [14C]-lasmiditan
- A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug UsersCompletedPhase 1Eli Lilly and CompanyNCT03286218Written as Lasmiditan
- The Effects of Lasmiditan on Simulated Driving Performance - Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT03012334Written as Lasmiditan
- A Study of Multiple Doses of Lasmiditan in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT03252015Written as Lasmiditan
- A Study of Lasmiditan in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT03182920Written as Lasmiditan
- Dose-ranging Study of Oral COL-144 in Acute Migraine TreatmentCompletedPhase 2Eli Lilly and CompanyNCT00883051Written as Lasmiditan
- Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:CompletedPhase 3Eli Lilly and CompanyNCT02439320Written as Lasmiditan 100 mg
- A Study of Lasmiditan and Propranolol in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT03270644Written as Lasmiditan
Codes
What other systems call lasmiditan · ClinicalTrials.gg INT005761
- MeSH (NLM) C554777lasmiditanConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 760I9WM792LASMIDITANConfirmed FDA, NLM, Wikidata
- RxNorm 2256930One source FDA
- Wikidata Q6493750lasmiditanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166996LasmiditanOne source FDA
- DrugBank DB11732One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C554777 | lasmiditan | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 760I9WM792 | LASMIDITAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2256930 | — | One source FDA |
| Wikidata | Q6493750 | lasmiditan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166996 | Lasmiditan | One source FDA |
| DrugBank | DB11732 | — | One source Wikidata |
Also registered as lasmiditan succinate (UNII W64YBJ346B).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.